Nordea Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Sell |
|
|||||
|
2025
Q1 | $2.21M | Buy |
|
|||||
|
2024
Q4 | $2.14M | Hold |
|
|||||
|
2024
Q3 | $1.71M | Buy |
|
|||||
|
2024
Q2 | $1.5M | Hold |
|
|||||
|
2024
Q1 | $1.3M | Buy |
|
|||||
|
2023
Q4 | $931K | Buy |
|
|||||
|
2023
Q3 | $902K | Sell |
|
|||||
|
2023
Q2 | $1.66M | Sell |
|
|||||
|
2023
Q1 | $2.11M | Buy |
|
|||||
|
2022
Q4 | $2.16M | Buy |
|
|||||
|
2022
Q3 | $570K | Sell |
|
|||||
|
2022
Q2 | $620K | Buy |
|
|||||
|
2022
Q1 | $608K | Hold |
|
|||||
|
2021
Q4 | $533K | Buy |
|
|||||
|
2021
Q3 | $597K | Hold |
|
|||||
|
2021
Q2 | $597K | Hold |
|
|||||
|
2021
Q1 | $687K | Sell |
|
|||||
|
2020
Q4 | $1.08M | Hold |
|
|||||
|
2020
Q3 | $1.02M | Sell |
|
|||||
|
2020
Q2 | $2.51M | Buy |
|
|||||
|
2020
Q1 | $898K | Hold |
|
|||||
|
2019
Q4 | $990K | Hold |
|
|||||
|
2019
Q3 | $676K | Hold |
|
|||||
|
2019
Q2 | $919K | Sell |
|
|||||
|
2019
Q1 | $1.6M | Buy |
|
|||||
|
2018
Q4 | $1.54M | Buy |
|
|||||
|
2018
Q3 | $2.14M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.25M | Hold |
|
|||||
|
2017
Q4 | $1.38M | Sell |
|
|||||
|
2017
Q3 | $3.09M | Sell |
|
|||||
|
2017
Q2 | $428M | Buy |
|
|||||
|
2017
Q1 | $403M | Sell |
|
|||||
|
2016
Q4 | $481M | Buy |
|
|||||
|
2016
Q3 | $599M | Buy |
|
|||||
|
2016
Q2 | $639M | Buy |
|
|||||
|
2016
Q1 | $598M | Buy |
|
|||||
|
2015
Q4 | $356M | Buy |
|
|||||
|
2015
Q3 | $208M | Sell |
|
|||||
|
2015
Q2 | $269M | Buy |
|
|||||
|
2015
Q1 | $280M | Buy |
|
|||||
|
2014
Q4 | $244M | Buy |
|
|||||
|
2014
Q3 | $152M | Buy |
|
|||||
|
2014
Q2 | $95.1M | Buy |
|
|||||
|
2014
Q1 | $90.6M | Sell |
|
|||||
|
2013
Q4 | $139M | Sell |
|
|||||
|
2013
Q3 | $178M | Buy |
|
|||||
|
2013
Q2 | $168M | Buy |
|